Kevin McCaffrey

Most Recent Articles by Kevin McCaffrey

Five things for pharma marketers to know: Friday, February 5, 2016

Five things for pharma marketers to know: Friday, February 5, 2016

Johnson & Johnson collaborates with biotech on diabetes stem-cell treatment; the FDA warms up to Remicade biosimilar; Woodcock warns about biosimilar backlog

House Oversight committee upbraids Turing, Valeant execs

House Oversight committee upbraids Turing, Valeant execs

A House lawmaker called pricing strategies used by Turing and Valeant "repulsive."

McCann Torre Lazur names new president

McCann Torre Lazur names new president

After Bill McEllen's departure, the company promoted Mark Willmann to lead the agency.

Five things for pharma marketers to know: Tuesday, February 2, 2016

Five things for pharma marketers to know: Tuesday, February 2, 2016

Gleevec generics hit shelves; four OxyContin patents are invalidated; Sanofi axes 600 positions

Dudnyk promotes Tobias to president after Powers

Dudnyk promotes Tobias to president after Powers

Plus other industry hires and changes

More Articles by Kevin McCaffrey

Email Newsletters